SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $450 | -99.9% | 10,721 | -20.9% | 0.04% | -35.7% |
| Q3 2022 | $531,000 | -12.4% | 13,557 | -27.7% | 0.07% | -23.1% |
| Q2 2022 | $606,000 | -45.3% | 18,750 | -28.0% | 0.09% | -34.5% |
| Q4 2021 | $1,108,000 | +198.7% | 26,035 | +211.0% | 0.14% | +265.8% |
| Q3 2021 | $371,000 | -62.4% | 8,371 | -51.8% | 0.04% | -65.8% |
| Q2 2021 | $987,000 | +75.9% | 17,381 | +167.9% | 0.11% | +20.7% |
| Q4 2020 | $561,000 | +93.4% | 6,487 | +36.7% | 0.09% | +91.7% |
| Q3 2020 | $290,000 | -52.8% | 4,744 | -77.8% | 0.05% | -68.8% |
| Q1 2020 | $614,000 | +38.0% | 21,374 | +246.6% | 0.15% | +196.2% |
| Q4 2019 | $445,000 | +8.8% | 6,167 | +10.1% | 0.05% | +225.0% |
| Q2 2015 | $409,000 | – | 5,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 181,650 | $15,715,000 | 7.17% |
| GREAT POINT PARTNERS LLC | 454,417 | $39,312,000 | 6.38% |
| ACUTA CAPITAL PARTNERS, LLC | 255,800 | $22,129,000 | 6.02% |
| Integral Health Asset Management, LLC | 195,000 | $16,869,000 | 5.02% |
| DAFNA Capital Management LLC | 181,306 | $15,685,000 | 4.67% |
| Boxer Capital, LLC | 1,094,000 | $94,642,000 | 3.04% |
| Palo Alto Investors LP | 590,200 | $51,058,000 | 2.68% |
| Bellevue Group AG | 1,567,504 | $135,604,000 | 1.55% |
| Aristotle Atlantic Partners, LLC | 160,805 | $13,911,000 | 1.07% |
| JGP Global Gestao de Recursos Ltda. | 2,618 | $226,000 | 0.85% |